Hayat Pharmaceutical Industries Co (AMM:HPIC) Ending Cash Position: JOD8.06 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
47 GF Score
Price JOD3.20
! 8 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co Ending Cash Position?

Hayat Pharmaceutical Industries Co AMM:HPIC +1.27% 47 Ending Cash Position is JOD8.06 Mil as of Jun. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 47/100. The stock has 8 warning signs investors should review.

Hayat Pharmaceutical Industries Co's Ending Cash Position for the quarter that ended in Jun. 2026 was JOD8.06 Mil.

Hayat Pharmaceutical Industries Co's quarterly Ending Cash Position increased from Dec. 2025 (JOD9.56 Mil) to Mar. 2026 (JOD10.31 Mil) but then declined from Mar. 2026 (JOD10.31 Mil) to Jun. 2026 (JOD8.06 Mil).

Hayat Pharmaceutical Industries Co's annual Ending Cash Position increased from Dec. 2023 (JOD7.25 Mil) to Dec. 2024 (JOD9.05 Mil) and increased from Dec. 2024 (JOD9.05 Mil) to Dec. 2025 (JOD9.56 Mil).

Hayat Pharmaceutical Industries Co Ending Cash Position Related Terms

Hayat Pharmaceutical Industries Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co Ending Cash Position Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.73 6.63 7.25 9.05 9.56

Hayat Pharmaceutical Industries Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.36 9.02 9.56 10.31 8.06
AMM:HPIC
47GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hayat Pharmaceutical Industries Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9.045+0.516
=9.56

Hayat Pharmaceutical Industries Co's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=10.308+-2.246
=8.06

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of JOD8.06 Mil mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Ending Cash Position of JOD8.06 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hayat Pharmaceutical Industries Co and its competitors.
Is Hayat Pharmaceutical Industries Co's Ending Cash Position too high?
Hayat Pharmaceutical Industries Co's current Ending Cash Position is JOD8.06 Mil. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Ending Cash Position compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's Ending Cash Position of JOD8.06 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hayat Pharmaceutical Industries Co and its competitors. Hayat Pharmaceutical Industries Co's current Ending Cash Position is JOD8.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a current Ending Cash Position of JOD8.06 Mil. The current Ending Cash Position is JOD8.06 Mil. Hayat Pharmaceutical Industries Co's overall GF Score™ is 47/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Ending Cash Position is JOD8.06 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
47GF Score

Get the complete analysis for AMM:HPIC

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.20
Price